StreetAlpha
13F holdings · Q3 2026

Velan Capital Investment Management

Alpharetta, GA · files as Velan Capital Investment Management LP
Know the moment Velan Capital Investment Management filesYou follow Velan Capital Investment Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1848809

Velan Capital Investment Management reported 42 stocks worth $105M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PRAX (21.3%), IMMX (10.8%) and TARA (8.3%). Compared with Q2 2026, the fund opened new positions in EWTX, QTTB and AARD, added to MPLT, EDSA and EVMN, trimmed PRAX, STRO and XNCR and sold out of TENX, RZLT and VRCA.

Latest filing: what Velan Capital Investment Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
6 new5 added5 trimmed14 sold outBought about $7.3M · sold about $28.3M
New 6
See all 6 →
Added 5
Trimmed 5
Sold out 14
See all 14 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$105M−35.9% vs last quarter
Stocks held426 new · 14 sold out
Top 5 weight54.5%fairly concentrated
Turnover34%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
PRAX
Praxis Precision Medicines I
$22.3M21.3%77K−12K (−14%)8 of 8
2
IMMX
Immix Biopharma Inc
$11.3M10.8%1.1MNo change6 of 8
3
TARA
Protara Therapeutics Inc
$8.7M8.3%2.8MNo change8 of 8
4
STRO
Sutro Biopharma Inc
$8.2M7.8%510K−2,122 (−0%)4 of 8
5
ABVX
Abivax SA
$6.5M6.2%66KNo change5 of 8
6
MPLT
Maplight Therapeutics Inc
$6.4M6.1%625K+132K (+27%)4 of 8
7
AVR
Anteris Technologies Global
$5.4M5.2%700KNo change3 of 8
8
EDSA
Edesa Biotech Inc
$5.4M5.2%1.3M+455K (+55%)7 of 8
9
AVTX
Avalo Therapeutics Inc
$5M4.8%324KNo change8 of 8
10
XNCR
Xencor Inc
$4.4M4.2%175K−80K (−31%)3 of 8
🔒 32 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
TENX
Tenax Therapeutics Inc
$8M550K
RZLT
Rezolute Inc
$3.9M750K
VRCA
Verrica Pharmaceuticals Inc
$2.9M472K
ADMA
Adma Biologics Inc
$2.1M250K
PROF
Profound Medical Corp
$1.1M170K

🔒 Free account: see all 14.

Options

valued at the underlying shares
StockTypeValueSharesChange
TENX
Tenax Therapeutics Inc
Call$130K69K0

Reported value

last 8 quarters
$116MQ4 '24
$97.2MQ1 '25
$99.9MQ2 '25
$106MQ3 '25
$172MQ4 '25
$160MQ1 '26
$163MQ2 '26
$105MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Velan Capital Investment Management 13F FAQ

What does Velan Capital Investment Management own?

Velan Capital Investment Management reported 42 stocks worth $105M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PRAX (21.3%), IMMX (10.8%) and TARA (8.3%). The table above lists every position in the filing (the top 10 without an account).

What did Velan Capital Investment Management buy and sell in Q3 2026?

Compared with Q2 2026: 6 new positions, 5 added to, 5 trimmed and 14 sold out. New positions include EWTX, QTTB and AARD. It sold all of TENX, RZLT and VRCA.

When will Velan Capital Investment Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Velan Capital Investment Management's portfolio worth?

The Q3 2026 filing reports $105M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.